OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

The Advantages of the Microneedle Array Patch

 
 
Harro HöfligerCarolyn MillerJune 20, 2020Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

OneVentures Venture Credit Fund poised to invest $120M into Australian scaleups

Media ReleaseCarolyn MillerJuly 22, 2020OneVentures
Next

Vaxxas announces that MSD exercises option to apply novel immune system activation platform for vaccine candidate

Media ReleaseCarolyn MillerMay 29, 2020Vaxxas, Paul Kelly

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd